2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome Amoxicillin, Levofloxacin, Ofloxacin - Short Bowel Syndrome, Infection, Bacterial | Phase 1 | Unknown | Central Hospital, Nancy, France | 10 | 2022-12-09 | 2024-08-29 |
| Proof of Concept Study in Patients With Short Bowel Syndrome NM-002 - Short Bowel Syndrome | Phase 1 / Phase 2 | Unknown | 9 Meters Biopharma, Inc. | 12 | 2020-06-23 | 2020-11-20 |
Short Bowel Syndrome (2) · Bacterial Infections (1)
Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Postoperative Complications (2) · Bacterial Infections and Mycoses (1) · Infections (1)
Amoxicillin (1) · Levofloxacin (1) · Ofloxacin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
9 Meters Biopharma, Inc. (1) · Central Hospital, Nancy, France (1)
France (1) · United States (1)
PMID 15530127, PMID 1559306, PMID 20094812, PMID 2292168, PMID 24667978, PMID 29127863, PMID 6699766, PMID 7619677, PMID 7924123, PMID 9724482